nanoTherics Overview

  • Founded
  • 2007
Founded
  • Status
  • Private
  • Employees
  • 2
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $379K
Latest Deal Amount
  • Investors
  • 6

nanoTherics General Information

Description

Developer of nano-magnetic instruments designed to use in medical and research applications. The company's instruments are used for cancer therapy, drug delivery, genetic screening and gene therapy programs, enabling healthcare providers to cure genetic disorders and diseases such as Parkinson's and cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Devices and Supplies
Therapeutic Devices
Primary Office
  • Brookside Farm, Dig Lane
  • Warrington
  • Cheshire WA2 0SH
  • England, United Kingdom
+44 01925 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

nanoTherics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 27-Jan-2016 $379K 00.000 00.000 Completed Generating Revenue
6. Grant 01-Oct-2015 000.00 00.000 Completed
5. Later Stage VC 06-Apr-2013 00000 00.000 00.000 Completed Generating Revenue
4. Grant 01-Mar-2011 00000 00.000 Completed Startup
3. Early Stage VC (Series A) 28-Jan-2011 00.000 00.000 00.000 Completed Startup
2. Seed Round 19-Feb-2009 $258K $258K 00000 Completed Startup
1. Grant 24-Dec-2008 $135K Completed Startup
To view nanoTherics’s complete valuation and funding history, request access »

nanoTherics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
A Ordinary 000 00.000000 000.00 000.00 00 000.00 0.000
B Ordinary 0,000 00.000000 000.00 000.00 00 000.00 00.000
B Ordinary 00,000 00.000000 000.00 000.00 00 000.00 00.000
Ordinary 0,000 00.000000 000.00 000.00 00 000.00 0.000
A Ordinary 0,000 00.000000 000.00 000.00 00 000.00 0.000
A Ordinary 00,000 00.000000 000.00 000.00 00 000.00 00.000
A Ordinary 0,000 00.000000 000.00 000.00 00 000.00 0.00
A Ordinary 000 00.000000 000.00 000.00 00 000.00 0.000
A Ordinary 730 $0.036144 $79.52 $79.52 1x $79.52 1.17%
A Shares 2,000 $0.036144 $57.83 $57.83 1x $57.83 3.22%
To view nanoTherics’s complete cap table history, request access »

nanoTherics Executive Team (4)

Name Title Board Seat Contact Info
Carlton Jones Chief Executive Officer & Board Member
You’re viewing 1 of 4 executive team members. Get the full list »

nanoTherics Board Members (7)

Name Representing Role Since
Brijesh Roy Ph.D Mercia Asset Management Board Member 000 0000
Carlton Jones nanoTherics Chief Executive Officer & Board Member 000 0000
You’re viewing 2 of 7 board members. Get the full list »

nanoTherics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

nanoTherics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Innovate UK Government 000 0000 000000 0
Minerva Business Angel Network Angel Group 000 0000 000000 0
Catapult Ventures Venture Capital Minority 000 0000 000000 0
Mercia Asset Management Venture Capital Minority 000 0000 000000 0
Advantage West Midlands Government 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »